These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7038207)

  • 1. [In-vitro prediction of clinical response to chemotherapy in leukemia].
    Shibata A; Takahashi M
    Nihon Rinsho; 1981 Aug; 39(8):2826-31. PubMed ID: 7038207
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemic colony (L-CFU) formation in vitro: clinical correlations of the in vitro growth pattern of L-CFU and drug sensitivity in acute leukemia.
    Moriyama Y; Sanada M
    Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1583-8. PubMed ID: 6675406
    [No Abstract]   [Full Text] [Related]  

  • 3. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics and practical consequences for therapy of acute leukemia.
    Bleich HL; Boro ES
    N Engl J Med; 1975 Aug; 293(8):389-93. PubMed ID: 1057045
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA
    Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.
    Fried J; Perez AG; Doblin J; Clarkson BD
    Cancer Treat Rep; 1981; 65(1-2):153-6. PubMed ID: 7194735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth response of residual leukemia after initial drug therapy.
    Karp JE; Burke PJ
    Cancer Res; 1986 Aug; 46(8):4205-7. PubMed ID: 3731087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chemotherapy on cell kinetics. II. Rauscher and Moloney murine leukemias].
    Najean Y; Faille A
    Nouv Rev Fr Hematol; 1973; 13(1):51-69. PubMed ID: 4352960
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell kinetics as related to treatment of patients with acute nonlymphoid leukemia.
    Lampkin BC
    Am J Pediatr Hematol Oncol; 1985; 7(4):358-72. PubMed ID: 2417503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the sensitivity to cytostatics of leukemia cells by labeling with tritiated thymidine and uridine: comparison with clinical response].
    Burgaleta C; Serrano LG; Moreno MT; Dancausa JP
    Sangre (Barc); 1985; 30(5):831-8. PubMed ID: 3867160
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of leukemic blast cells in man and the cytokinetic effect of cytostatic agents in vivo.
    Killmann SA; Wantzin GL
    Nouv Rev Fr Hematol (1978); 1982; 24(4):213-9. PubMed ID: 7145696
    [No Abstract]   [Full Text] [Related]  

  • 13. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronization with phase-specific agents in leukemia and correlation with clinical response to chemotherapy.
    Vogler WR; Kremer WB; Knospe WH; Omura GA; Tornyos K
    Cancer Treat Rep; 1976 Dec; 60(12):1845-59. PubMed ID: 1026339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro test for studying sensitivity to Ara-C in leukemic patients].
    Onetto N; Momparler RL; Momparler LF; Gyger M; Rivard GE
    Union Med Can; 1987 Feb; 116(2):114-6. PubMed ID: 3564185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytostatics in hematology].
    Gross R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(3):109-28. PubMed ID: 4114893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of daunorubicin and cytarabine on cell line NB4].
    Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic differences in leukemic cells (L1210) exposed to 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Iwasaki H; Aoyama H; Ueda T; Uchida M; Nakamura T
    Anticancer Res; 1992; 12(3):941-7. PubMed ID: 1622152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.